Follow us on:
Breaking News
September 11, 2026
CP Direct: Friday Edition
Breaking News
Schott AG_CP_Leaderboard_0926

The Future of R&D: Orchestrating Lab Transformation

 
The Future of R&D: Orchestrating Lab Transformation

Discover how pharma labs are orchestrating lab transformation with unified, AI-driven data systems that cut errors and speed R&D breakthroughs.
Read More >>

Solvias_Webinar_09-22-26_Leaderboard
Top Headlines

Friday Brief
Videos

The Friday Brief for September 11, 2026: Facility Openings and Expansions

Meanwhile, bioprocessing and drug discovery drove some of the major new partnerships of the week.

SPONSOR

Used Pharmaceutical Manufacturing and Processing Equipment

Federal Equipment Company has on-hand inventory in more than 200 categories of OEM-brand equipment in clean, climate-controlled warehouses, enabling you to quickly source processing and packaging equipment you need from a supplier with over 60 years of experience.

Breaking News
Collaborations & Alliances

Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company

The agreement extends manufacturing commitments through 2033 and pushes Samsung Biologics’ cumulative contract value above $21.9 billion.

Breaking News
Collaborations & Alliances

Exegenesis Bio, Modalis Partner on DMD Gene Therapy

The collaboration pairs Exegenesis Bio’s EMC181 muscle-tropic AAV capsid with Modalis’ CRISPR-GNDM platform to advance MDL-201.

SPONSOR

Is Your CRO CDMO Partnership Truly Integrated, or Just Combined?

Join Kirk Bray of Thermo Fisher Scientific to explore how clinical supply chain connects decisions, materials, and teams across the development lifecycle. Free live webinar, September 17. Save your seat now.

ContractPharma_Conference_2026_650x250

Breaking News

Lonza to Add Commercial Spray-Drying Facility in Oregon

The facility is expected to be completed in 2029, and will add 80 new jobs.

Breaking News
Collaborations & Alliances

Glenmark, South Piedmont Launch Pharma Training Facility

The 21,000-square-foot facility will train students for careers in aseptic and sterile pharmaceutical manufacturing.

SPONSOR

New eBook: Elevating Quality and Compliance in Sterile Injectable Fill-Finish

Learn strategies for managing evolving GMP expectations, reducing contamination risk, and supporting advanced biologics and drug-device production.

Features

Inside the Changing HPAPI Manufacturing Landscape

Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.

Featured Resources

Solution Center SPOTLIGHT

INCOG BioPharma Services

INCOG BioPharma is a global fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products. Our facility is FDA approved, Annex 1 compliant, and uses the latest technology to provide tailored manufacturing solutions. We fill into syringes, vials, and cartridges, and offer autoinjector assembly, final packaging solutions, and in-house analytics. Our experienced team creates value for customers by decreasing manufacturing times and simplifying complex supply chains, enabling drug developers to focus on advancing their therapies with confidence.

 

Solution Center SPOTLIGHT

Quality Chemical Laboratories (QCL)

QCL is a CDMO privately owned and operated since 1998. We excel in pre-formulation, formulation development, and delivering early phase clinical trial materials on aggressive timelines. We provide analytical development and validation, stability studies, and testing of small and large molecule APIs, finished products, and raw materials. New construction doubles our footprint to 200,000 sq. ft., expanding services into late phase clinical and small scale commercial GMP manufacturing including state of the art sterile fill-finish for both small and large molecules.